Article History
Accepted: 11 October 2023
First Online: 16 November 2023
Declarations
:
: No external funding was received to assist with preparation of this article.
: Georgia Biazus Soares has no conflicts of interest that are directly relevant to the content of this article. Joan Guitart is a consultant for Kyowa Kirin and Castle Diagnostics. Gil Yosipovitch serves as an advisory board member for Abbvie, Arcutis, BMS, Cara Therapuetics, GSK, Escient Health, Eli Lilly, Galderma, Kiniksa Pharmaceuticals, LEO Pharma, Novartis, Pfizer, Pierre Fabre, Regeneron Pharmaceuticals, Inc., Sanofi, TreviTherapeutics, and Vifor; has received grants/research funding from Eli Lilly, Kiniksa Pharmaceuticals, LEO Pharma, Novartis, Pfizer, Galderma, Escient, Sanofi Regeneron, and Celldex; and has received pathways grants as an Investigator for Regeneron Pharmaceuticals, Inc. and Sanofi.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Conceptualization: GBS, GY; writing, original draft preparation: GBS; writing, review and editing: JG, GY.